Riehl melanosis - I-Riehl Melanosishttps://en.wikipedia.org/wiki/Riehl_melanosis
I- I-Riehl Melanosis (Riehl melanosis) iwuhlobo lwe-contact dermatitis, oluqala ngokuluma, i-erythema, ne-pigmentation esakazeka kancane kancane okuthi, ngemva kokufinyelela izinga elithile, ibe imile. Ukuchayeka elangeni ngemva kokusetshenziswa kwamakha athile noma okhilimu kungase kubangele lesi sifo.

☆ Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
      References Riehl Melanosis 32491369 
      NIH
      Riehl melanosis ivamise ukwaziwa ngokuthi i-pigmented contact dermatitis. Kuwuhlobo lwesimo sesikhumba esibangelwa ukungezwani komzimba nezinto ezithile, ngokuvamile esibangelwa amakha nezinye izinto ezitholakala emikhiqizweni yezimonyo. Naphezu kokuhlukaniswa njengohlobo lwe-dermatitis, Riehl melanosis ibonisa izinguquko zombala esikhumbeni, ezinezimpawu ezincane kuphela zokucasuka. Kuvame kakhulu kubantu abanesikhumba esimnyama. Ucwaningo lwakamuva luhlole ukusebenza kahle kokwelashwa nge-laser kwe- mid-fluence QSNY 1064-nm ukubhekana nokujula kombala okuhlobene ne- Riehl melanosis. Olunye ucwaningo luhlanganise izindlela zokwelapha ezihlukene, okuhlanganisa i- low-fluence 1064-nm Q-switched Nd: YAG i-laser, ukhilimu we-hydroquinone, ne-oral tranexamic acid, okubangele ukuthuthuka okuphawulekayo ezigulini eziningi.
      Riehl melanosis (RM), commonly called pigmented contact dermatitis, is considered an acquired form of allergic contact dermatitis, typically to fragrance and other ingredients of cosmetic products. Although it is considered as a dermatitis, it presents clinically with hyperpigmentation over the face and shows pigment incontinence with minimal eczematous changes on histology. The condition is more commonly seen in dark-skinned people, causing an important psychosocial impact. A recent study showing the higher effectiveness of mid-fluence QSNY 1064-nm laser in targetting the deep pigmentation of RM has also been conducted. Another study used a combination of therapies to include low-fluence, 1064-nm, Q-switched Nd: YAG laser, hydroquinone cream, and oral tranexamic acid, with the majority of patients experiencing significant improvement.
       Research Advances in the Treatment of Riehl’s Melanosis 37168093 
      NIH
      I- Riehl's melanosis wuhlobo lwesimo sesikhumba esibangelwa ukuthintana nezinto ezithile ezingezwani nokudla kanye nokuchayeka elangeni. Kuholela esikhumbeni esisheshayo, esithuthukayo sombala ompunga, esingathinta kakhulu iziguli ngokwengqondo nangokomzimba. Nakuba imbangela yangempela ye- Riehl's melanosis ingakaziwa, ucwaningo olukhona lubonisa isixhumanisi esinamandla sokuchayeka kwe-allergen. Ukuze uthole ukwelashwa, kokubili imithi yendabuko kanye nokwelashwa nge-laser kuye kwazanywa, ngokuvamile okuhambisana nokusetshenziswa kwama-bleaching agents afakwa esikhumbeni. Ukwelashwa nge-laser, ikakhulukazi kusetshenziswa i-laser engu- Q-switched Nd:YAG , kubonise imiphumela ethembisayo yokwelapha i- Riehl's melanosis. Ukuhlanganisa izindlela ezahlukene zokwelapha kuholele emiphumeleni emihle.
      Riehl's melanosis (RM) is a contact photodermatitis, with fast progressive gray-brown skin pigmentation as the main manifestation, which can seriously affect the psychology and physiology of patients. Currently, although the etiological factors of Riehl's melanosis is still be unknown, the existing literature proves clearly the cause of it is related to the contacting with suspected allergens. For decades, there has been no standard method for the treatment of RM, but with both conventional drug therapy and laser therapy having been attempted. Topical application of bleaching agents is mainly used as an auxiliary treatment modality. The laser treatment modality remains a hot spot, among which Q-switched Nd:YAG laser is well received for RM. Positive outcomes have been achieved by the combined treatment modalities attempted in recent years also achieve positive outcomes.